News & Events

Featured Blog: TreeFrog Therapeutics Q&A

Today, we’re highlighting the groundbreaking work of TreeFrog Therapeutics, a company aimed at making stem cell-derived cell therapies more affordable and accessible to millions of patients. TreeFrog is a resident of our newest facility, LabCentral 238, with on-site capacities to kickstart collaborative cell therapy programs in regenerative medicine and immuno-oncology. We spoke with TreeFrog’s Cofounder and Chief Technology Officer, Kevin Alessandri, Ph.D., who just moved from Bordeaux to Boston, to learn more about the company’s focus and activities.

Learn More

Gallery 1832

Gallery 1832 provides residents and visitors with new avenues to find inspiration in the space around them. We believe this constantly changing environment and exposure to new perspectives is beneficial to the mind. In this spirit, the gallery space is an important part of keeping life fresh for researchers and entrepreneurs. 

Learn More

Press Releases

LabCentral Ignite Launches Fourth Annual Golden Ticket Contest May 30, 2024

Six Ignite Golden Tickets offer opportunity for underrepresented biotech entrepreneurs and scientists to benefit from LabCentral's lab space, shared resources and community CAMBRIDGE, Mass., May 30,…Read full post

LabCentral 2023 Impact Report Details a Decade of Innovation and Economic Development for Biotech and Life Sciences Startups in Massachusetts May 7, 2024

Since its founding in 2013, LabCentral has supported 278 companies that have created 6,339 new jobs, secured $18.4 billion in funding, launched 132 clinical trials and been awarded 180 new…Read full post

A Partnership Built to Last: Eppendorf Renews Founding Sponsorship with LabCentral March 27, 2024

The globally active Eppendorf Group proudly announces the 5-year partnership renewal with LabCentral, a renowned life sciences incubator, dedicated to empowering innova-tive biotech startups. As a…Read full post

LabCentral Joins ARPA-H Investor Catalyst Hub Spoke Network March 25, 2024

‐New program, the largest of its kind, provides private lab space for innovative growth-stage biotech companies at state-of-the-art Kendall Square site - NORTHBROOK, Ill. and CAMBRIDGE, Mass., March…Read full post

LabCentral and Astellas Launch Inaugural $500,000 "Diamond Ticket" at LabCentral 238 March 5, 2024

Eight Golden Tickets offer more opportunity for underrepresented biotech entrepreneurs and scientists to benefit from LabCentral's lab space, shared resources and community CAMBRIDGE, Mass., May 15,…Read full post

See All Press Releases